(1888PressRelease)
August 04, 2008 - The Pharma Competitive Intelligence Conference is on track to becoming the industry event of the year to be held at the Woodbridge Hotel in Iselin, New Jersey on September 15-17, 2008. Besides the unprecedented 40 senior level biopharma speakers confirmed, 250 attendees are expected as well. There will be 30 hours of sessions on the most pressing topics of today and 10 hours of exclusive networking time. We invite you to join in the discussions and become critical contributors of the future success of the pharmaceutical industry.
“The conference focuses solely on topics of key importance,” says Amy Yueh, the conference organizer. “Participants will gain insight about the election implications for pharma, the crucial role intelligence plays in times of economic uncertainty, strategic insights in new product planning and business development, the growing importance of China in this space, increasing CI productivity and effectiveness, the latest technology developments, patent analysis, positioning your company for 2010, outsourcing/ off-shoring CI, examining generic developments in the US and EU, CI in medical devices and diagnostics, and much more.”
We are also introducing a special program track for medical device and drug delivery practitioners as this field continues to experience tremendous growth.
Highlights of the conference include:
• Unrivaled speaker faculty
• Ratio of industry attendees vs. vendor attendees is 4:1
• Unparalleled networking- all the key decision makers will be there
• 3 concurrent tracks to customize interest
• Large exhibition
A special thank you to our 2008 Conference Advisory Board:
Robert Franc, Director of Competitive Intelligence, Centocor
Monika Giese, Head of Global Competitive Intelligence, Novartis Pharma AG
Craig McHenry, Senior Director, Competitor Insights, Wyeth
Shacker Mourad, Director, Strategy Analysis and Intelligence, AstraZeneca
Daniel R. Pascheles, Vice President, Global Competitive Intelligence, Merck
Renee Pierson, Global Intelligence Leader, Johnson & Johnson
Chandra Ramanathan, Director, Global Business and Competitive Intelligence, Bristol-Myers Squibb
Dawn Renear, Vice President, Competitive & Technical Information, Genzyme
Hu Song, Director, Business Information WW, Ethicon, a Johnson & Johnson company
Sue Ward, Director, Information & Knowledge Management, Pfizer
The speaking faculty includes all the "Who's Who" of intelligence professionals from pharma, biotech, medical devices, and diagnostics, which include the following companies: Actelion, Alcon Laboratories, Amgen, ANS, AstraZeneca, Bayer HealthCare, BD Diagnostics, Biovail, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Centocor, ConvaTecEisai, Eli Lilly, Ethicon, Exelixis, Genentech, Genzyme, Johnson & Johnson, Medrad, Merck, Millennium, Novartis, Novo Nordisk, OSI Pharmaceuticals, Pfizer, Phillips Medical Systems, MEDRAD, Roche Laboratories, Sanofi-Aventis, Schering-Plough, TAP, Thermo Fisher Scientific, Wyeth, and ZymoGenetics.
2008 sponsors/exhibitors include the following: Best Practices, BioMedTracker, Cipher Systems, CIS Life Sciences, Deallus, Denodo, Digimind, dtw Marketing Research Group, Dunn Group, Evaluate Pharma, Fletcher/CSI, Fuld & Company, Gerson Lehrman Group, Indegene, InfoNgen, Indigo Research, ISIS Global, Life Science Analytics, Lifescience Dynamics, MedPredict, MedTrack, Navigate International, Nerac, Open Options, PharmaForce, and PharmaVoxx, Power Capital Consulting, QL2, Sedulo Group.
For the detailed program agenda and additional information, please visit www.pharmaciconference.com or contact Amy Yueh at +1.212.228.7974/ ayueh ( @ ) pharmaciconference dot com.
###
